Alternative pathway to endothelin-converting enzyme for the synthesis of endothelin in human blood vessels

Journal of Cardiovascular Pharmacology

Volumn 44, Issue SUPPL. 1, 2004, Pages

  Maguire, Janet ^a   Davenport, Anthony P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Big endothelin 1; Chymase; Endothelin 1; Endothelin converting enzyme; Human umbilical vein; PD159790

Indexed keywords

CHYMASE; CHYMOSTATIN; ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN CONVERTING ENZYME INHIBITOR; PD 159790;

CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG RESPONSE; ENZYME SYNTHESIS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; UMBILICAL VEIN; VENOCONSTRICTION;

ASPARTIC ENDOPEPTIDASES; CHYMASES; ENDOTHELIN-1; HUMANS; METALLOENDOPEPTIDASES; OLIGOPEPTIDES; POTASSIUM CHLORIDE; SERINE PROTEINASE INHIBITORS; UMBILICAL VEINS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 11144314960     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000166219.65593.af     Document Type: Conference Paper

References (11)

1. Wypij DM, Nichols JS, Novak PJ, et al. Role of mast-cell chymase in the extracellular processing of big-endothelin-1 to endothelin-1 in the perfused rat lung. Biochem Pharmacol. 1992;43(4):845-853.
2. Nakano A, Kishi F, Minami K, et al. Selective conversion of big endothelins to tracheal smooth muscle-constricting 31-amino acid-length endothelins by chymase from human mast cells. J Immunol. 1997;159:1987-1992.
3. Kido H, Nakano A, Okishima N, et al. Human chymase, an enzyme forming novel bioactive 31-amino acid length endothelins. Biol Chem. 1998;379:885-891.
4. (1-31), in mammary and coronary arteries in vivo. Br J Pharmacol. 2001;134:1360-1366.
5. Urata H, Kinoshita A, Misono KS, et al. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem. 1990;265(36):22348-22357.
6. Voors AA, Pinto YM, Buikema H, et al. Dual pathway for angiotensin II formation in human internal mammary arteries. Br J Pharmacol. 1998;125:1028-1032.
7. Takai S, Jin D, Sakaguchi M, Miyazaki M. Chymase-dependent angiotensin II formation in human vascular tissue. Circulation. 1999;100:654-658.
8. Davenport AP, Hoskins SL, Kuc, RE, Plumpton C. Differential distribution of endothelin peptides and receptors in human adrenal gland. Histochem J. 1996;28:779-789.
9. Maguire JJ. Endothelin-converting enzyme activity in vascular smooth muscle preparations in vitro. In: Maguire JJ, Davenport AP, eds. Peptide Research Protocols: Endothelin. Totowa, NJ: Humana Press, 2002.
10. Ahn K, Sisneros AM, Herman SB, et al. Novel selective quinazoline inhibitors of endothelin converting enzyme-1. Biochem Biophys Res Commun. 1998;243:184-190.
11. Maguire JJ, Johnson CM, Mockridge JW, Davenport AP. Endothelin converting enzyme (ECE) activity in human vascular smooth muscle. Br J Pharmacol. 1997;122:1647-1654.